Abstract
Several lines of evidence implicate dopa decarboxylase (DDC) with schizophrenia. By analysis of two putative functional DDC variants in 173 schizophrenic patients and 204 controls we tested the hypotheses that DDC is involved in: (1)?predisposition to schizophrenia; and (2)?modulation of age at disease onset. No association was observed with schizophrenia as a whole, whereas an association between DDC genotypes and age at disease onset was suggested in males (P?=?0.03). This association was most pronounced in relation to genotypes of haplotypes comprising both variants, suggesting an additive model where one variant mediates early and the other late onset. Accordingly, the haplotype-based genotypes could be assigned into three groups by their possible relative effect on age at onset: an ‘early’, ‘neutral’ and ‘late’ group. Dividing the male schizophrenics into four groups with increasing age at onset, the ‘early’ genotypes were seen to decrease in frequency from 51.5% to 16.7% while the ‘late’ genotypes increased from 12.1% to 33.3% (P?=?0.02). The difference in mean age at onset between male patients with ‘early’ genotypes vs patients with ‘late’ genotypes was close to 5 years (95% CI: 0.7–8.8). Thus, DDC may possibly act as a modulator of age at onset in male schizophrenics.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
Purchase on Springer Link
Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Davis KL, Kahn RS, Ko G, Davidson M . Dopamine in schizophrenia: a review and reconceptualization Am J Psychiatry 1991 148: 1474–1486
Waddington JL . Schizophrenia: developmental neuroscience and pathobiology Lancet 1993 341: 531–536
Weinberger DR . Neurodevelopmental perspectives on schizophrenia. In: Bloom FE, Kupfer DJ (eds) Psychopharmacology: The Fourth Generation of Progress Raven Press: New York 1995 1171–1183
Christenson JG, Dairman W, Udenfriend S . On the identity of DOPA decarboxylase and 5-hydroxytryptophan decarboxylase (immunological titration-aromatic L-amino acid decarboxylase-serotonin-dopamine-norepinephrine) Proc Natl Acad Sci USA 1972 69: 343–347
Davis BA, Shrikhande S, Paralikar VP, Hirsch SR, Durden DA, Boulton AA . Phenylacetic acid in CSF and serum in Indian schizophrenic patients Prog Neuropsychopharmacol Biol Psychiatry 1991 15: 41–47
O'Reilly R, Davis BA, Durden DA, Thorpe L, Machnee H, Boulton AA . Plasma phenylethylamine in schizophrenic patients Biol Psychiatry 1991 30: 145–150
Reith J, Benkelfat C, Sherwin A, Yasuhara Y, Kuwabara H, Andermann F et al. Elevated dopa decarboxylase activity in living brain of patients with psychosis Proc Natl Acad Sci USA 1994 91: 11651–11654
Buckland PR, Marshall R, Watkins P, McGuffin P . Does phenylethylamine have a role in schizophrenia?: LSD and PCP up-regulate aromatic L-amino acid decarboxylase mRNA levels Brain Res Mol Brain Res 1997 49: 266–270
Angermeyer MC, Kuhn L . Gender differences in age at onset of schizophrenia. An overview Eur Arch Psychiatry Neurol Sci 1988 237: 351–364
Hafner H, Behrens S, De Vry J, Gattaz WF . An animal model for the effects of estradiol on dopamine-mediated behavior: implications for sex differences in schizophrenia Psychiatry Res 1991 38: 125–134
Børglum AD, Bruun TG, Kjeldsen TE, Ewald H, Mors O, Kirov G et al. Two novel variants in the DOPA decarboxylase gene: association with bipolar affective disorder Mol Psychiatry 1999 4: 545–551
Speight G, Turic D, Austin J, Hoogendoorn B, Cardno AG, Jones L et al. Comparative sequencing and association studies of aromatic L-amino acid decarboxylase in schizophrenia and bipolar disorder Mol Psychiatry 2000 5: 327–331
Terwilliger JD, Ott J . Handbook of Human Genetic Linkage The Johns Hopkins University Press: Baltimore, London 1994
Meltzer HY, Maes M, Lee MA . The cimetidine-induced increase in prolactin secretion in schizophrenia: effect of clozapine Psychopharmacology (Berl) 1993 112: S95–S104
Kolakowska T, Williams AO, Ardern M, Reveley MA, Jambor K, Gelder MG et al. Schizophrenia with good and poor outcome. I: Early clinical features, response to neuroleptics and signs of organic dysfunction Br J Psychiatry 1985 146: 229–239
Nimgaonkar VL, Wessely S, Tune LE, Murray RM . Response to drugs in schizophrenia: the influence of family history, obstetric complications and ventricular enlargement Psychol Med 1988 18: 583–592
Eaton WW, Mortensen PB, Herrman H, Freeman H, Bilker W, Burgess P et al. Long-term course of hospitalization for schizophrenia: Part I. Risk for rehospitalization Schizophr Bull 1992 18: 217–228
Meltzer HY, Rabinowitz J, Lee MA, Cola PA, Ranjan R, Findling RL, Thompson PA . Age at onset and gender of schizophrenic patients in relation to neuroleptic resistance Am J Psychiatry 1997 154: 475–482
Johnstone EC, Owens DG, Bydder GM, Colter N, Crow TJ, Frith CD . The spectrum of structural brain changes in schizophrenia: age of onset as a predictor of cognitive and clinical impairments and their cerebral correlates Psychol Med 1989 19: 91–103
Loebel AD, Lieberman JA, Alvir JM, Mayerhoff DI, Geisler SH, Szymanski SR . Duration of psychosis and outcome in first-episode schizophrenia Am J Psychiatry 1992 149: 1183–1188
Häfner H, Riecher-Rossler A, Maurer K, Fatkenheuer B, Loffler W . First onset and early symptomatology of schizophrenia. A chapter of epidemiological and neurobiological research into age and sex differences Eur Arch Psychiatry Clin Neurosci 1992 272: 109–118
Bellodi L, Morabito A, Macciardi F, Gasperini M, Benvenuto MG, Grassi G et al. Analytic considerations about distribution of age of onset in schizophrenia Neuropsychobiology 1982 8: 93–101
Rzewuska M, Angst J . Aspects of the course of bipolar manic-depressive, schizo-affective, and paranoid schizophrenic psychoses Arch Psychiatr Nervenkr 1982 231: 487–501
Beratis S, Gabriel J, Hoidas S . Age at onset in subtypes of schizophrenic disorders Schizophr Bull 1994 20: 287–296
Ellinwood EH, Jr, Sudilovsky A, Nelson LM . Evolving behavior in the clinical and experimental amphetamine (model) psychosis Am J Psychiatry 1973 130: 1088–1093
Snyder SH . Amphetamine psychosis: a ‘model’ schizophrenia mediated by catecholamines Am J Psychiatry 1973 130: 61–67
Buckland PR, Spurlock G, McGuffin P . Amphetamine and vigabatrin down regulate aromatic L-amino acid decarboxylase mRNA levels Brain Res Mol Brain Res 1996 35: 69–76
Endicott J, Spitzer RL . A diagnostic interview: the schedule for affective disorders and schizophrenia Arch Gen Psychiatry 1978 35: 837–844
Spitzer RL, Endicott J, Robins E . Research Diagnostic Criteria (RDC) for a Selected Group of Functional Disorders, 3rd edn New York State Psychiatric Institution: Biometrics Research Division 1978
Acknowledgements
The study was supported by grants from the Danish Medical Research Council (9602007), the Scottish Medical Research Council (grant to Drs D Blackwood and W Muir), the European Union (BMH4-CT97-2466), the Psychiatric Research Foundation, the Eli and Egon Larsen Foundation, the Geert-Jørgensen Foundation, the Jacob Madsen Foundation, and the Axel Thomsen Foundation. Dr V Murray is supported by a Sim Fellowship from the Royal College of Physicians of Edinburgh. We are grateful for the help of the Regional Blood transfusion Service, Edinburgh. Anette B Kvistgaard and Peter Lodge are acknowledged for excellent laboratory work.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Børglum, A., Hampson, M., Kjeldsen, T. et al. Dopa decarboxylase genotypes may influence age at onset of schizophrenia. Mol Psychiatry 6, 712–717 (2001). https://doi.org/10.1038/sj.mp.4000902
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.mp.4000902
Keywords
This article is cited by
-
Common Variation in the DOPA Decarboxylase (DDC) Gene and Human Striatal DDC Activity In Vivo
Neuropsychopharmacology (2016)
-
The role of cerebellar genes in pathology of autism and schizophrenia
The Cerebellum (2008)
-
Evidence implicating BRD1 with brain development and susceptibility to both schizophrenia and bipolar affective disorder
Molecular Psychiatry (2006)
-
Multi-locus association study of schizophrenia susceptibility genes with a posterior probability method
Science in China Series C: Life Sciences (2005)